Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice

Expert panelists review key data from recent meetings on the management of multiple myeloma and consider how these can be applied to clinical practice.

EP. 1: Frontline Quadruplet Therapy in NDMM: GRIFFIN and MASTER Studies

May 10th 2022

Expert perspectives on frontline daratumumab-containing quadruplet regimens in the context of recent clinical trials in newly diagnosed multiple myeloma.

EP. 2: Frontline Quadruplet Therapy in NDMM: GMMG-HD7

May 10th 2022

Shared insight on the GMMG-HD7 study, which utilized a frontline isatuximab-containing quadruplet regimen in patients with newly diagnosed multiple myeloma.

EP. 3: NDMM Management: Assessing Response and Determining Duration of Therapy

May 17th 2022

Comprehensive insight on optimizing newly diagnosed multiple myeloma management, ranging from response assessment to use of consolidation and maintenance therapy.

EP. 4: Case Presentation 1: Selecting Therapy in Transplant-Ineligible NDMM

May 17th 2022

Centering discussion on a patient case of transplant-ineligible newly diagnosed multiple myeloma, experts consider how they would approach workup and management.